The present disclosure relates to medical devices and methods for treating cardiac arrythmias. More specifically, the disclosure relates to devices and methods for cryogenically ablating cardiac tissue.
Cardiac arrhythmias involve an abnormality in the electrical conduction of the heart and are a leading cause of stroke, heart disease, and sudden cardiac death. Treatment options for patients with arrhythmias include medications, implantable devices, and catheter ablation of cardiac tissue.
Catheter ablation involves delivering ablative energy to tissue inside the heart to block aberrant electrical activity from depolarizing heart muscle cells out of synchrony with the heart's normal conduction pattern. The procedure is performed by positioning the tip of an energy delivery catheter adjacent to diseased or targeted tissue in the heart. The energy delivery component of the system is typically at or near the most distal (furthest from the operator) portion of the catheter, and often at a tip of the device. Various forms of energy are used to ablate diseased heart tissue. These can include radio frequency (RF), cryogenics, ultrasound and laser energy, to name a few. The tip of the catheter is positioned adjacent to diseased tissue, at which time energy is delivered to create tissue necrosis, rendering the ablated tissue incapable of conducting electrical signals. The dose of the energy delivered is a critical factor in increasing the likelihood that the treated tissue is permanently incapable of conduction. At the same time, delicate collateral tissue, such as the esophagus, the bronchus, and the phrenic nerve surrounding the ablation zone can be damaged and can lead to undesired complications. Thus, the operator must finely balance delivering therapeutic levels of energy to achieve intended tissue necrosis while avoiding excessive energy leading to collateral tissue injury.
Atrial fibrillation (AF) is one of the most common arrhythmias treated using catheter ablation. In the earliest stages of the disease, paroxysmal AF, the treatment strategy involves isolating the pulmonary veins from the left atrial chamber. Recently, the use of techniques known as “balloon cryotherapy” catheter procedures to treat AF have increased. In part, this stems from the balloon cryotherapy's ease of use, shorter procedure times and improved patient outcomes. Despite these advantages, there remains needed improvement to further improve patient outcomes and to better facilitate real-time physiological monitoring of tissue to optimally titrate energy to perform both reversible “ice mapping” and permanent tissue ablation.
There remains an unmet need for an expansible tissue ablation device that is capable of providing effective therapeutic ablative energy and reliable physiological monitoring to improve delivery of ablative energy to achieve improved therapeutic outcomes. There is also a need to reduce excessive energy delivery that causes collateral tissue injury. The device should ideally control the amount of therapeutic energy based on real-time physiological monitoring to control the amount of ablative energy delivered to the tissue at a specified target location. This should include a manner of modulating ablative energy output based on real-time interrogation of tissue parameters such as temperature, device contact force, local blood pressure, etc.
Moreover, there is an unmet need for a device which can seamlessly integrate physiological monitoring sensors and ablative elements without compromising the function of the device in administering therapeutic energy or enabling device conversion between a collapsed state and an expanded state.
Further, there is a need for a cryoablation balloon catheter that treats atrial fibrillation and other arrhythmias, which can sense tissue parameters in realtime before, during and after ablation. Currently, the “mapping” function in cryoablation catheters is often handled by separate accessory devices. Adding conventional sensors to a balloon can add undesirable bulk to the balloon, which would necessitate a larger delivery sheath to introduce into and retract from the body of the patient.
There have been several attempts to attach sensors or mapping electrodes to balloons, all with limited success. Some disadvantages to earlier solutions include added bulk or balloon profile, a tendency for the electrodes to peel off a balloon during expansion and contraction, and difficulty routing wires to connect to the electrodes, to name a few.
The present invention is directed toward an intravascular catheter system for treating a condition in a body. In one embodiment, the intravascular catheter system includes a catheter shaft, a first inflatable balloon and a plurality of electrodes. The catheter shaft has a shaft distal end that is selectively positioned within the body. The first inflatable balloon is positioned near the distal end of the catheter shaft. The first inflatable balloon is configured to move between an inflated state and a substantially deflated state. In the inflated state, the first inflatable balloon has a maximum circumference. The plurality of electrodes are attached to the first inflatable balloon. The plurality of electrodes can sense a physiological parameter within the body. Further, the plurality of electrodes can be positioned away from the maximum circumference of the first inflatable balloon so that none of the electrodes are positioned on the maximum circumference of the first inflatable balloon.
In certain embodiments, the first inflatable balloon has an inner surface and an opposed outer surface. In some such embodiments, the electrodes are positioned on the inner surface of the first inflatable balloon.
In another embodiment, the first inflatable balloon has an inner surface and an opposed outer surface. In this embodiment, the electrodes are positioned on the outer surface of the first inflatable balloon. In various embodiments, the intravascular catheter system can also include one or more flex circuits that are secured to the first inflatable balloon. In certain such embodiments, the electrodes are coupled to the first inflatable balloon via the one or more flex circuits. In various embodiments, the one or more flex circuits can be positioned away from the maximum circumference of the first inflatable balloon. In some embodiments, each of the flex circuits can be secured to the first inflatable balloon distal to the maximum circumference.
In certain embodiments, at least two electrodes are positioned on each of the one or more flex circuits. In some such embodiments, two of the electrodes on each flex circuit form a thermocouple.
In various embodiments, at least eight flex circuits are positioned on the first inflatable balloon. Alternatively, at least twelve flex circuits are positioned on the first inflatable balloon.
In some embodiments, the inflatable balloon includes a plurality of spines when the first inflatable balloon is in the substantially deflated state. In certain embodiments, two flex circuits are positioned between two adjacent spines. In some embodiments, two adjacent two flex circuits substantially face one another when the first inflatable balloon is in the substantially deflated state.
In another embodiment, the intravascular catheter system can also include a second inflatable balloon that is positioned within the first inflatable balloon. In some such embodiments, the second inflatable balloon has an outer surface and an opposed inner surface, and the plurality of electrodes are positioned on the outer surface of the second inflatable balloon.
In various embodiments, the intravascular catheter system also includes a guidewire lumen and a guidewire that is positioned at least partially within the guidewire lumen. The first inflatable balloon can be attached to the guidewire lumen. The intravascular catheter system can also include a controller and a plurality of conductors. In certain embodiments, each conductor carries an electrical signal between at least one of the electrodes and the controller. The electrical signal can be based on the physiological parameter.
In some embodiments, the guidewire lumen has a lumen distal end, and each conductor is routed from at least one of the electrodes to the controller via the lumen distal end of the guidewire lumen.
In certain embodiments, the intravascular catheter system can also include a pair of reference electrodes that are positioned away from the first inflatable balloon. In these embodiments, the pair of reference electrodes can form a thermocouple that senses a temperature of a portion of the body. The reference electrodes can generate a reference sensor output. In various embodiments, two of the plurality of electrodes generate a sensor output that is compared to the reference sensor output to determine a temperature of a portion of the body.
In another embodiment, the intravascular catheter system can include a catheter shaft, a first inflatable balloon, a flex circuit and a pair of electrodes. The catheter shaft can have a shaft distal end that is selectively positioned within the body. The first inflatable balloon can be positioned near the distal end of the catheter shaft. The first inflatable balloon can be configured to move between an inflated state and a substantially deflated state. The flex circuit can be attached to the first inflatable balloon. The pair of electrodes can be secured to the flex circuit. The pair of electrodes can sense a physiological parameter within the body.
In a further embodiment, the intravascular catheter system can include a catheter shaft, a first inflatable balloon and a plurality of electrodes. The catheter shaft can have a shaft distal end that is selectively positioned within the body. The first inflatable balloon can be positioned near the distal end of the catheter shaft. The first inflatable balloon can be configured to move between an inflated state and a substantially deflated state. The first inflatable balloon has an inner surface and an opposed outer surface. The plurality of electrodes each senses a physiological parameter within the body. In certain embodiments, the plurality of electrodes are attached to the inner surface of the first inflatable balloon.
In yet another embodiment, the intravascular catheter system includes a catheter shaft, a first inflatable balloon, a plurality of electrodes and two flex circuits. The catheter shaft can have a shaft distal end that is selectively positioned within the body. The first inflatable balloon can be positioned near the distal end of the catheter shaft. The first inflatable balloon can be configured to move between an inflated state and a substantially deflated state. The plurality of electrodes sense one or more physiological parameters within the body. The two flex circuits couple the electrodes to the first inflatable balloon. In some embodiments, the two flex circuits can each be attached to the first inflatable balloon. In various embodiments, the two flex circuits substantially face one another when the first inflatable balloon is in the substantially deflated state.
While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.
The novel features of this invention, as well as the invention itself, both as to its structure and its operation, will be best understood from the accompanying drawings, taken in conjunction with the accompanying description, in which similar reference characters refer to similar parts, and in which:
While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.
Embodiments of the present invention are described herein in the context of a cryogenic balloon catheter system (also hereinafter sometimes referred to as an “intravascular catheter system”). Those of ordinary skill in the art will realize that the following detailed description of the present invention is illustrative only and is not intended to be in any way limiting. Other embodiments of the present invention will readily suggest themselves to such skilled persons having the benefit of this disclosure. Reference will now be made in detail to implementations of the present invention as illustrated in the accompanying drawings.
In the interest of clarity, not all of the routine features of the implementations described herein are shown and described. It will, of course, be appreciated that in the development of any such actual implementation, numerous implementation-specific decisions must be made in order to achieve the developer's specific goals, such as compliance with application-related and business-related constraints, and that these specific goals will vary from one implementation to another and from one developer to another. Moreover, it will be appreciated that such a development effort might be complex and time-consuming, but would nevertheless be a routine undertaking of engineering for those of ordinary skill in the art having the benefit of this disclosure.
Although the disclosure provided herein focuses mainly on cryogenics, it is understood that various other forms of energy can be used to ablate diseased heart tissue. These can include radio frequency (RF), ultrasound and laser energy, as non-exclusive examples. The present invention is intended to be effective with any or all of these and other forms of energy.
In various embodiments, the control system 14 can control release and/or retrieval of a cryogenic fluid 26 to and/or from the balloon catheter 18. In various embodiments, the control system 14 can control activation and/or deactivation of one or more other processes of the balloon catheter 18. Additionally, or in the alternative, the control system 14 can receive electrical signals, including data and/or other information (hereinafter sometimes referred to as “sensor output”) from various structures within the cryogenic balloon catheter system 10. In some embodiments, the control system 14 can assimilate and/or integrate the sensor output, and/or any other data or information received from any structure within the cryogenic balloon catheter system 10. Additionally, or in the alternative, the control system 14 can control positioning of portions of the balloon catheter 18 within the body of the patient 12, and/or can control any other suitable functions of the balloon catheter 18.
The fluid source 16 contains the cryogenic fluid 26, which is delivered to the balloon catheter 18 with or without input from the control system 14 during a cryoablation procedure. The type of cryogenic fluid 26 that is used during the cryoablation procedure can vary. In one non-exclusive embodiment, the cryogenic fluid 26 can include liquid nitrous oxide. However, any other suitable cryogenic fluid 26 can be used.
The balloon catheter 18 is inserted into the body of the patient 12. In one embodiment, the balloon catheter 18 can be positioned within the body of the patient 12 using the control system 14. Alternatively, the balloon catheter 18 can be manually positioned within the body of the patient 12 by a health care professional (also sometimes referred to herein as an “operator”). In certain embodiments, the balloon catheter 18 is positioned within the body of the patient 12 utilizing the sensor output from the balloon catheter 18. In various embodiments, the sensor output is received by the control system 14, which then can provide the operator with information regarding the positioning of the balloon catheter 18. Based at least partially on the sensor output feedback received by the control system 14, the operator can adjust the positioning of the balloon catheter 18 within the body of the patient 12. While specific reference is made herein to the balloon catheter 18, it is understood that any suitable type of medical device and/or catheter may be used.
The handle assembly 20 is handled and used by the operator to operate, position and control the balloon catheter 18. The design and specific features of the handle assembly 20 can vary to suit the design requirements of the cryogenic balloon catheter system 10. In the embodiment illustrated in
In the embodiment illustrated in
The graphical display 24 provides the operator of the cryogenic balloon catheter system 10 with information that can be used before, during and after the cryoablation procedure. The specifics of the graphical display 24 can vary depending upon the design requirements of the cryogenic balloon catheter system 10, or the specific needs, specifications and/or desires of the operator.
In one embodiment, the graphical display 24 can provide static visual data and/or information to the operator. In addition, or in the alternative, the graphical display 24 can provide dynamic visual data and/or information to the operator, such as video data or any other data that changes over time. Further, in various embodiments, the graphical display 24 can include one or more colors, different sizes, varying brightness, etc., that may act as alerts to the operator. Additionally, or in the alternative, the graphical display can provide audio data or information to the operator.
In one embodiment, the inner inflatable balloon 230A can be made from a relatively non-compliant or semi-compliant material. Some representative materials suitable for this application include PET (polyethylene terephthalate), nylon, polyurethane, and co-polymers of these materials such as polyether block amide (PEBA), known under its trade name as PEBAX® (supplier Arkema), as nonexclusive examples. In another embodiment, a polyester block copolymer known in the trade as Hytrel® (DuPont™) is also a suitable material for the inner inflatable balloon 230A. The inner inflatable balloon 230A can be relatively inelastic in comparison to the outer inflatable balloon 232A.
In certain embodiments, the outer inflatable balloon 232A can be made from a relatively compliant material. Such materials are well known in the art. One non-exclusive example is aliphatic polyether polyurethanes in which carbon atoms are linked in open chains, including paraffins, olefins, and acetylenes. Another available example goes by the trade name Tecoflex® (Lubrizol). Other available polymers from the polyurethane class of thermoplastic polymers with exceptional elongation characteristics are also suitable for use as the outer inflatable balloon 232A. In one embodiment, either of the balloons 230A, 232A, may be rendered electrically conductive by doping the material from which it is made with a conductive metal or other conductive substance. These electrically conductive balloons are particularly suitable for the outer inflatable balloon 232A described herein.
During use, the inner inflatable balloon 230A can be partially or fully inflated so that at least a portion of the outer surface 240A of the inner inflatable balloon 230A expands against an inner surface 242A of the outer inflatable balloon 232A (although a space is shown between the inner inflatable balloon 230A and the outer inflatable balloon 232A in
In the embodiment illustrated in
The sensor assembly 234A is configured to sense one or more physiological parameters within the pulmonary vein 236A. Further, the sensor assembly 234A can provide sensor output regarding the physiological parameters to the control system 14 (illustrated in
In one embodiment, the first sensor 252AF, the second sensor 252AS and the third sensor 252AT can include, in no particular order, a pressure sensor, a temperature sensor and an electrode, or any combination thereof. Alternatively, the first sensor 252AF, the second sensor 252AS and the third sensor 252AT can include a plurality of the same type of sensor, and can exclude one or more types of sensors. In one embodiment, the pressure sensor, e.g. a microelectromechanical systems or “MEMS” sensor, can sense the pressure within the blood of the pulmonary vein 236A. The temperature sensor can sense the temperature of the blood within the pulmonary vein 236A. The electrode can sense electrical potentials within the blood of the pulmonary vein 236A. The uses and benefits of these types of sensors during cryogenic ablation procedures are well known and understood.
Additionally, or in the alternative, one of the sensors 252AF, 252AS, 252AT (or an additional sensor within the sensor assembly 234A), can include an ultrasound device/sensor which can assist in determining a location of the guidewire 226A, the guidewire lumen 227A and/or the sensor assembly 234A within the circulatory system of the patient 212. More specifically, the ultrasound device/sensor can provide a sensor output that accurately shows a user of the cryogenic balloon catheter system 21 OA the location of the sensor assembly 234A within the pulmonary vein 236A while the cryogenic balloon catheter system 21 OA is in use.
In certain embodiments, the control system 14 (illustrated in
The control system 14 can abort the delivery of cryogenic fluid 26 (illustrated in
As shown in
In one embodiment, the sensor assembly 234A can be at least partially, if not fully, covered by a sensor outer cover 255A. The sensor outer cover 255A can include an elastomeric material that isolates one or more of the sensors 252AF, 252AS, 252AT, from the blood in the circulatory system of the patient 212, and can inhibit damage to one or more of the sensors 252AF, 252AS, 252AT, during insertion and removal from the patient 212. In one embodiment, the sensor outer cover 255A can be part of the guidewire lumen 227A. The sensor assembly 234A can also be housed within a sensor housing 256A that can form part of the guidewire lumen 227A.
The inner inflatable balloon 230C and the outer inflatable balloon 232C can be constructed from materials in a somewhat similar manner as those previously described herein. Further, the inner inflatable balloon 230C and the outer inflatable balloon 232C can operate in a somewhat similar manner as previously described herein. However, in the embodiment illustrated in
In this embodiment, the sensor assembly 234C is configured to sense one or more physiological parameters near or within the pulmonary vein 236C. Further, the sensor assembly 234C can provide sensor output to the control system 14 (illustrated in
The sensors 252CF, 252CS, 252CT, can operate in a somewhat similar manner as those previously described herein. In certain embodiments, the control system 14 is configured to process and integrate the sensor output to determine proper functioning of the cryogenic balloon catheter system 210C. Based on the sensor output, the control system 14 can determine that certain modifications to the functioning of the cryogenic balloon catheter system 210C are required.
Although the foregoing embodiments show and describe various sensors being positioned either (1) between the lumen distal end 246A and the outer inflatable balloon 232A, or (2) between the inner inflatable balloon 230C and the outer inflatable balloon 232C, it is recognized that an alternative embodiment can include one or more sensors being positioned between the lumen distal end 246A and the outer inflatable balloon 232A, and one or more sensors being positioned between the inner inflatable balloon 230C and the outer inflatable balloon 232C. In other words, sensors can be positioned in both locations in this alternative embodiment without deviating from the spirit of the cryogenic balloon catheter system 10 described herein. Additionally, one or more of the sensors can be positioned on the guidewire 226A. All of the data collected from the sensors, regardless of the position of the sensors, can be sent to the control system 14 for use by a user (health care physician or other user) or by the control system 14 itself.
An alternative embodiment includes placing a pressure sensor into an assembly comprised of three conductors, a sensor housing, and a sealed tube enclosing the wiring. In this embodiment, the assembly is routed internally through the catheter, from the shaft distal end of the catheter shaft to the handle assembly and/or the control system.
In the embodiment illustrated in
In this embodiment, the inflatable balloon 568 can represent either the inner inflatable balloon 230A (illustrated in
The sensor assembly 534 can include a plurality of electrodes 572 that are secured to the inflatable balloon 568 on an outer surface 240A (illustrated in
In the embodiment illustrated in
In the embodiment illustrated in
In one embodiment, the flex circuits 574 are in electrical communication with the control system 14 (illustrated in
In the deflated state, the inflatable balloon 568 becomes somewhat pleated to permit spines 576 between one or more of the flex circuits 574, which each contains at least one electrode pair 573 of electrodes 572. With this design, the flex circuits 574 themselves are not folded when the inflatable balloon 568 is in the deflated state. However, spines 576 between the flex circuits 574 inhibit unwanted peeling off of the flex circuits 574 from the inflatable balloon 568 during deflation and while in the deflated state. Further, in the deflated state, the inflatable balloon 568 is pleated which facilitates a smaller, more organized profile of the inflatable balloon 568 for removal from the body of the patient 12 (illustrated in
In one embodiment, in the deflated state, two flex circuits 574 are positioned between two adjacent spines 576. In one embodiment, the two flex circuits 574 that are positioned between two adjacent spines 576 are adjacent to one another. Alternatively, the two flex circuits 574 that are positioned between two adjacent spines 576 need not be adjacent to one another. With this design, two such adjacent flex circuits 574 and/or two adjacent electrode pairs 573 will substantially face one another upon deflation of the inflatable balloon 568. Stated another way, in one embodiment, the inflatable balloon 568 will include a pleat or crease between two such adjacent flex circuits 574 and/or the two such adjacent electrode pairs 573, such that each two such adjacent flex circuits 574 will substantially face one another when the inflatable balloon 568 is substantially and/or completely deflated.
In this embodiment, the flex circuits 574 will alternate substantially facing an adjacent flex circuit 574 on one side, and facing substantially away from the other adjacent flex circuit 574 on an opposite side of the spine 576 when the inflatable balloon 568 is substantially completely deflated. In such embodiment, two flex circuits 574 are positioned between two adjacent spines 576 of the inflatable balloon 568. In other words, as the spines 576 are moved closer toward one another when the inflatable balloon 568 is in the deflated state, the two flex circuits 574 that are positioned between two adjacent spines 576 can rotate toward one another so that the flex circuits 574 substantially face one another. Further, with this design, folding or creasing of the flex circuits 574 is inhibited.
It is understood that although a number of different embodiments of the cryogenic balloon catheter system 10 have been illustrated and described herein, one or more features of any one embodiment can be combined with one or more features of one or more of the other embodiments, provided that such combination satisfies the intent of the present invention.
While a number of exemplary aspects and embodiments of a cryogenic balloon catheter system 10 have been discussed above, those of skill in the art will recognize certain modifications, permutations, additions and sub-combinations thereof. It is therefore intended that the following appended claims and claims hereafter introduced are interpreted to include all such modifications, permutations, additions and sub-combinations as are within their true spirit and scope.
Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of the present invention is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.
This application is a continuation of International Application No. PCT/US18/16026, with an international filing date of Jan. 30, 2018, which claims the benefit of U.S. Provisional Application No. 62/452,973, filed on Jan. 31, 2017 and entitled “CRYOGENIC BALLOON CATHETER ASSEMBLY WITH SENSOR ASSEMBLY”, and U.S. Provisional Application No. 62/613,722, filed on Jan. 4, 2018, and entitled “CRYOGENIC BALLOON CATHETER ASSEMBLY WITH SENSOR ASSEMBLY”. As far as permitted, the contents of International Application No. PCT/US18/16026 and U.S. Provisional Application Nos. 62/452,973 and 62/613,722 are incorporated herein by reference for all purposes.
Number | Date | Country | |
---|---|---|---|
62613722 | Jan 2018 | US | |
62452973 | Jan 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2018/016026 | Jan 2018 | US |
Child | 16527570 | US |